These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38800569)

  • 1. Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada.
    Iablokov V; Gregor J; Chande N; Ponich T; Jairath V; Khanna R; Asfaha S
    Crohns Colitis 360; 2024 Apr; 6(2):otae031. PubMed ID: 38800569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use amongst patients with inflammatory bowel disease.
    Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists.
    Regueiro M; Hunter T; Lukanova R; Shan M; Wild R; Knight H; Bannikoppa P; Naegeli AN
    Adv Ther; 2023 Feb; 40(2):474-488. PubMed ID: 36370288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.
    Coates MD; Dalessio S; Walter V; Stuart A; Bernasko N; Tinsley A; Razeghi S; Williams ED; Clarke K; Vrana K
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):445-450. PubMed ID: 33998892
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients.
    Wang G; Tandon P; Rodriguez N; Ambrosio L; Sutton RT; Dieleman LA; Kroeker KI; Huang V
    Dig Dis Sci; 2023 Apr; 68(4):1156-1166. PubMed ID: 35930124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States.
    Desai R; Patel U; Goyal H; Rimu AH; Zalavadia D; Bansal P; Shah N
    Ann Transl Med; 2019 Jun; 7(12):252. PubMed ID: 31355219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
    Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
    Storr M; Devlin S; Kaplan GG; Panaccione R; Andrews CN
    Inflamm Bowel Dis; 2014 Mar; 20(3):472-80. PubMed ID: 24407485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.
    Kochar B; Martin CF; Kappelman MD; Spiegel BM; Chen W; Sandler RS; Long MD
    Am J Gastroenterol; 2018 Jan; 113(1):72-79. PubMed ID: 28853727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal Urgency Among Patients With Ulcerative Colitis or Crohn's Disease: Analyses from a Global Survey.
    Ha C; Naegeli AN; Lukanova R; Shan M; Wild R; Hennessy F; Jyothi Kommoju U; Potts Bleakman A; Hunter Gibble T
    Crohns Colitis 360; 2023 Oct; 5(4):otad052. PubMed ID: 37928613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
    Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases.
    Hlavaty T; Krajcovicova A; Koller T; Toth J; Nevidanska M; Huorka M; Payer J
    World J Gastroenterol; 2014 Nov; 20(42):15787-96. PubMed ID: 25400464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivations behind complementary and alternative medicine use in patients with Crohn's disease and ulcerative colitis.
    Klemm N; Trasolini R; Bressler B; Rosenfeld G; Almasan G; Leung Y
    J Can Assoc Gastroenterol; 2024 Oct; 7(5):376-383. PubMed ID: 39416725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Inflamm Bowel Dis; 2020 Mar; 26(4):502-509. PubMed ID: 31613959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey.
    Neufeld T; Pfuhlmann K; Stock-Schröer B; Kairey L; Bauer N; Häuser W; Langhorst J
    Z Gastroenterol; 2021 Oct; 59(10):1068-1077. PubMed ID: 34157755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.